Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey

Actively recruiting top talent to support US market penetration -
READING, England and BEDMINSTER, New Jersey, August 23, 2010 – Archimedes Pharma, an emerging specialty pharma company focused on
oncology, pain, neurology and critical care sectors, announced today the
location of its new US headquarters in Bedminster, New Jersey.

Archimedes has offices in a [...]

PRA International to Exhibit at ESC’s Annual Conference

Opportunity to Meet with PRA Experts
RALEIGH, North Carolina, August 23, 2010 – PRA International, a leading Clinical Research Organization, will exhibit
our cardiology expertise and experience at the European Society of
Cardiology's (ESC) annual conference in Stockholm, Sweden from 28 August to 1
September 2010.

At PRA booth C18:62, attendees can schedule meetings with [...]

Gold Standard/Elsevier Promotes Medication Safety and Compliance via New MEDcounselor Languages with Consumer Medication Information in 12 Foreign Languages

MEDcounselor Languages Improves Communications With Low-English Proficiency Patients, Ensures Provider Compliance With Language Access Services (LAS) Requirements

TAMPA, Florida, August 23, 2010 – Gold Standard/Elsevier, (www.goldstandard.com/) a leading
developer of drug information and medication management solutions, announced
today the launch of MEDcounselor Languages, a module that provides trusted
MEDcounselor (www.goldstandard.com/pages/medCounselor.html?epm=1_1)
consumer medication information in 12 foreign languages. The new [...]

American Medical Systems Receives CE Mark for AdVance(R) Xtra Performance (XP) Male Sling System

MINNETONKA, Minnesota, August 24, 2010 – American Medical Systems(R) (AMS) (Nasdaq: AMMD), a leading provider of
world-class devices and therapies for both male and female pelvic health,
announced today the company received CE (Conformite Europeenne) Mark for
AdVance XP. The device is the latest generation of AMS' AdVance sling, a
minimally invasive implant for the treatment of male [...]

Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan

LONDON, August 24, 2010 – While the penetration of picture archiving and communication systems
(PACS) in European hospitals is 80 per cent, the modern radiology information
system (RIS) that drives PACS has only reached a penetration level of about
41 per cent. Legacy RIS modules ubiquitously dominate the market and many
hospitals are reluctant to install a new [...]

Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors

Rubinfeld expected to assist with FDA approval process for autologous cultured skin substitute, PermaDerm(TM)

NEW YORK, August 24, 2010 – Regenicin, Inc. (www.regenicin.com) (OTC Bulletin Board: WDSTD), a
clinical-stage biotechnology company, announced today that Dr. Joseph
Rubinfeld, one of the four original founders of Amgen, Inc.
(www.amgen.com), has agreed to join the company's board of directors.
Dr. Rubinfeld will [...]

CAS Chemistry Research Report: A Decade Later Human Genome Discoveries Spur Growth of Cancer Treatments

COLUMBUS, Ohio, August 24, 2010 – Today, leukemia patients who have struggled with cancer therapy
resistance and intolerance will now have more options thanks to targeted drug
therapy. Such new treatment options are due, in part, to a rapid increase in
journal and patent publications following the discovery of Gleevec, as
reported by Chemical Abstracts Service (CAS), the [...]

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives

BEIJING, August 24, 2010 – Cellonis Biotechnologies, a Beijing and HK-based medical research and
application company, has recorded some remarkable results in the treatment of
a twelve-year-old boy with diabetes using their stem cell therapy in a
Beijing partner hospital. He has completely regained his normal life,
enjoying sports and school activities just like every other person his [...]

Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China

EDMONTON, Alberta, August 24, 2010 – Isotechnika Pharma Inc. ("Isotechnika") (TSX: ISA), a biopharmaceutical
company focused on the discovery and development of immune modulating
therapeutics, and 3SBio Inc. ("3SBio") (NASDAQ: SSRX), a leading China-based
biotechnology company focused on researching, developing, manufacturing and
marketing biopharmaceutical products, today announced the signing of a
development and commercialization agreement for voclosporin, a [...]

Pentasa(R) – Shire Receives Ruling From FDA on Citizen’s Petition

DUBLIN and PHILADELPHIA, August 24, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiary Shire
Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition
relating to Pentasa.

The ruling granted-in-part and denied-in-part the requests from Shire.
Shire had requested the FDA to issue formal [...]

Frost & Sullivan: Growing Demand for Effective Patient Record Keeping in Hospitals Drives the Electronic Medical Records Market in Europe

LONDON, August 25, 2010 – Due to deficiencies in present administrative and record-keeping
capacities, hospitals across Europe are under tremendous pressure to improve
clinical practices. As inefficient trends permeate hospital management, the
adoption of electronic medical record (EMR) solutions has become paramount.
Designed to constantly report and monitor care pathways, EMRs reduce the
number of data entry errors, inadequate [...]

UC Irvine School of Medicine’s Revolutionary iPad Program to Utilize E-Textbooks from Elsevier

First-year Med Students Will Access Four Key Titles, Including Netter: Atlas of Human Anatomy, From Their UCI-furnished iPads

PHILADELPHIA, August 26, 2010 – Elsevier, a world-leading publisher of scientific, technical
and medical information products and services, announced today it will
provide four key electronic textbook titles for UC Irvine School of
Medicine's new program that gives Apple iPads [...]

Pharma-Biotech Licensing Deals – Stopgap Option or Way of the Future? – Frost & Sullivan Web Conference

LONDON, August 26, 2010 – 2009 and 2010 have seen some of the biggest mergers, acquisitions and
licensing activities the pharmaceutical industry has undergone in a very long
time. In light of dwindling pipeline products, impending patent expirations
for several blockbuster drugs, tight budgets and cost cuts due to the
recession, several major pharmaceutical companies are looking at [...]

DePuy Orthopaedics Voluntarily Recalls ASR(TM) Hip System

WARSAW, Indiana, August 26, 2010 – DePuy Orthopaedics, Inc., announced it is voluntarily recalling the
ASR(TM) XL Acetabular System and DePuy ASR(TM) Hip Resurfacing System used in
hip replacement surgery due to the number of patients who required a second
hip replacement procedure, called a revision surgery.

The majority of ASR hip replacement surgeries [...]

STALLERGENES: Excellent 1st Half-Year 2010 Performance

ANTONY, France, August 27, 2010 -

– First Half-Year 2010 RESULTS

– Excellent 1st Half-Year 2010 Performance by Stallergenes

– Growth in France and Internationally +13%

– Very Strong net Profit Growth +51%

– Free Cash Flow Growth +90%

[...]

Gold Standard/Elsevier First to Launch State, Federal Controlled Substance Drug Schedules, Helping Ensure Safe, Compliant Prescribing and Dispensing

New Alchemy Module Allows Healthcare Providers to Verify and Comply With State and Federal Prescription Drug Regulations

TAMPA, Florida, August 27, 2010 – Gold Standard/Elsevier, developer of drug databases and medication
management solutions, announced today the availability of its new Alchemy
(www.goldstandard.com/pages/alchemy.html?epm=1_1) State and Federal
module, the first and only database to offer both state and federal
controlled substance [...]

Essilor – First-Half 2010 Results

CHARENTON-LE-PONT, France, August 27, 2010 -

– A Very Good First Half

– Sharp Increase in Revenue: up 15.8%
– High Contribution Margin Maintained, at 18.0% of Revenue
– Adjusted Earnings per Share: up 17.6%
– Strong Increase in [...]

STALLERGENES: Excellent 1st Half-Year 2010 Performance

ANTONY, France, August 27, 2010 -

– First Half-Year 2010 RESULTS

– Excellent 1st Half-Year 2010 Performance by Stallergenes

– Growth in France and Internationally +13%

– Very Strong net Profit Growth +51%

– Free Cash Flow Growth +90%

[...]

Gold Standard/Elsevier First to Launch State, Federal Controlled Substance Drug Schedules, Helping Ensure Safe, Compliant Prescribing and Dispensing

New Alchemy Module Allows Healthcare Providers to Verify and Comply With State and Federal Prescription Drug Regulations

TAMPA, Florida, August 27, 2010 – Gold Standard/Elsevier, developer of drug databases and medication
management solutions, announced today the availability of its new Alchemy
(www.goldstandard.com/pages/alchemy.html?epm=1_1) State and Federal
module, the first and only database to offer both state and federal
controlled substance [...]

Elsevier and Royal Tropical Institute Sign 5 Year Memorandum of Understanding to Provide ScienceDirect and Scopus to 150 Developing Country Researchers

MoU Drives Research Usage and Access with Virtual Knowledge Community
AMSTERDAM, August 27, 2010 – Elsevier and the Royal Tropical Institute (KIT) in Amsterdam announced on
26th of August the signing of a Memorandum of Understanding (MoU) providing
150 researchers working in least-developed and low-income countries (for
example Benin, Mozambique, Ethiopia, Togo etc.) with access to ScienceDirect
and Scopus, [...]

International Leaders Stress the Importance of Spatial Data Strategies for Improved Government Delivery

JOHANNESBURG, August 26, 2010 – Carlos Zeferino Torreblanca Galindo, Governor of the State of Guerrero,
Mexico and the former mayor of Acapulco spoke of the poverty within his
state. Demographic data he showed put his state near the bottom of most
statistics in basic services. Most support comes from the federal government
but by the time the state [...]

WHO and International Epilepsy Organisations Expose Unacceptable State of Epilepsy Care Across Europe

New Report Provides Recommendations to Improve the Quality of Care and Understanding of Epilepsy, and Reduce Stigmatisation to Help Bring Epilepsy 'Out of the Shadows'

PORTO, Portugal, August 26, 2010 – The World Health Organization (WHO) and the two international epilepsy
organisations, the International Bureau for Epilepsy (IBE) and the
International League Against Epilepsy (ILAE), have today [...]

Hikma – Half Year Results Interviews With CEO and CFO

LONDON, August 26, 2010 – Hikma Pharmaceuticals reports half year profit growth and raises gross
margin guidance.

In a video interview on www.cantos.com, Hikma CEO Said Darwazah says a
good performance at the company's three divisions supported the results. "All
three engines have been performing quite well, to give us these fantastic
results."
[...]

Ganeden Biotech and ICAM Announce Private Label Probiotic Chocolates

Innovative private label chocolate program gives store brand managers functional snack offer that hits on two hot consumer categories: probiotics and premium chocolate

CLEVELAND, August 26, 2010 – Ganeden Biotech, Inc. (www.ganedenlabs.com), maker of the patented
probiotic strain GanedenBC30(R) (www.ganedenbc30.com), and ICAM
S.p.A., an Italian farm-to-bar producer of all natural premium chocolates,
today announced Chocolate Plus Private Label, [...]

UC Irvine School of Medicine’s Revolutionary iPad Program to Utilize E-Textbooks from Elsevier

First-year Med Students Will Access Four Key Titles, Including Netter: Atlas of Human Anatomy, From Their UCI-furnished iPads

PHILADELPHIA, August 26, 2010 – Elsevier, a world-leading publisher of scientific, technical
and medical information products and services, announced today it will
provide four key electronic textbook titles for UC Irvine School of
Medicine's new program that gives Apple iPads [...]

Pharma-Biotech Licensing Deals – Stopgap Option or Way of the Future? – Frost & Sullivan Web Conference

LONDON, August 26, 2010 – 2009 and 2010 have seen some of the biggest mergers, acquisitions and
licensing activities the pharmaceutical industry has undergone in a very long
time. In light of dwindling pipeline products, impending patent expirations
for several blockbuster drugs, tight budgets and cost cuts due to the
recession, several major pharmaceutical companies are looking at [...]

DePuy Orthopaedics Voluntarily Recalls ASR(TM) Hip System

WARSAW, Indiana, August 26, 2010 – DePuy Orthopaedics, Inc., announced it is voluntarily recalling the
ASR(TM) XL Acetabular System and DePuy ASR(TM) Hip Resurfacing System used in
hip replacement surgery due to the number of patients who required a second
hip replacement procedure, called a revision surgery.

The majority of ASR hip replacement surgeries [...]

Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

CAMBRIDGE, Massachusetts, August 26, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today that the European Commission has
granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human
cell line derived enzyme replacement therapy (ERT) for the long-term
treatment of type 1 Gaucher disease. VPRIV has been authorized as an orphan
medicine through the [...]

Meeting the Demands of Staff in the Healthcare Sector

ABU DHABI, UAE, August 26, 2010 – The head of the nation's biggest hospital yesterday explained how the UAE
can overcome the worldwide shortage of medical staff, days after a report
revealed that the number of doctors and nurses will have to double within a
decade.

www.virtualpressoffice.com/eventsSubmenuForSearch.do?showId=977&e
nableHistory=EventsTab&myLink=myEventsSubmenu&fromSearch=T
(Due to the length [...]

Celebrity Beauties Joanna Lumley, Joss Stone and Lucy Davis Speak the Ugly Truth About Cruel Botox Animal Tests for the BUAV

LONDON, August 25, 2010 – Celebrity beauties Joanna Lumley, Joss Stone and Lucy Davis have joined
the BUAV to end cruel botox tests on animals. They were shocked to learn that
every batch of botox that hits the high street is tested on animals. Botox is
used by huge numbers of people worldwide for cosmetic purposes.

[...]

Frost & Sullivan: Growing Demand for Effective Patient Record Keeping in Hospitals Drives the Electronic Medical Records Market in Europe

LONDON, August 25, 2010 – Due to deficiencies in present administrative and record-keeping
capacities, hospitals across Europe are under tremendous pressure to improve
clinical practices. As inefficient trends permeate hospital management, the
adoption of electronic medical record (EMR) solutions has become paramount.
Designed to constantly report and monitor care pathways, EMRs reduce the
number of data entry errors, inadequate [...]

When a Condom is Not Enough

LONDON, August 25, 2010 – After today's news that the frequency of sexually transmitted disease is
increasing in the UK, particularly in adolescents and young adults, we asked
Dr Malcolm VandenBurg (www.malcolmvandenburg.co.uk/), a Harley Street
Private Specialist in Medicine including Sexual Health and General Medicine,
for his comments.

He is particularly well placed to give [...]

Fortis Hospitals India Does Asia’s First Custom Fit Knee Replacement Surgery

BANGALORE, India, August 24, 2010 – Combining the latest technology, medical breakthroughs and
personalized patient care, Fortis Hospitals Bangalore today announced Asia's
first 'Custom Fit Knee Replacement Surgery' performed on a series of
patients. Dr. Sanjay Pai, Chief Orthopedic Surgeon, along with his team
performed this revolutionary surgery for the first time in the Asian
Continent by precisely matching [...]

Eisai Announces Positive Phase III Trial Results for Perampanel in Partial Epilepsy

HATFIELD, England, August 24, 2010 – Eisai today announced the results of a Phase III study for the
investigational compound perampanel (E2007), a first-in-class, highly
selective non-competitive AMPA-type glutamate receptor antagonist, discovered
by Eisai and under development for adjunctive treatment of partial seizures
in patients with epilepsy.

The double-blind, placebo-controlled, parallel-group study (Study 306)
showed that [...]

Vitala(TM) Continence Control Device Now Indicated for Use With Convexity in European Union

Innovative Pouchless Ostomy Management System for People with a Colostomy
SKILLMAN, New Jersey, August 24, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today that the
Vitala(TM) Continence Control Device (CCD), the company's novel, non-invasive
pouchless ostomy device that provides temporary continence for people with an
end colostomy, has [...]

American Medical Systems Receives CE Mark for AdVance(R) Xtra Performance (XP) Male Sling System

MINNETONKA, Minnesota, August 24, 2010 – American Medical Systems(R) (AMS) (Nasdaq: AMMD), a leading provider of
world-class devices and therapies for both male and female pelvic health,
announced today the company received CE (Conformite Europeenne) Mark for
AdVance XP. The device is the latest generation of AMS' AdVance sling, a
minimally invasive implant for the treatment of male [...]